Cures Within Reach has an open Request for Proposals for clinical repurposing trials impacting any blood cancer, with a preference for trials impacting multiple myeloma and/or myelodysplastic syndromes. Eligible trials can come from anywhere in the world and must repurpose approved drugs, devices, nutraceuticals, diagnostics and/or approved cellular/gene therapies, alone or in combination, already used in clinical care for a different indication. Budgets of up to US$75,000 are accepted, and brief Letter of Intent submissions are on ProposalCentral at https://bit.ly/submittocwr using the Disease Specific Repurposing Research program by 29 July 2024. Contact clare@cureswithinreach.org with any questions about submitting, budget, deadline extensions, etc.